In people with Type 2 diabetes, obesity, and chronic kidney disease, bariatric or weight loss surgery can significantly protect kidney function and reduce the risk of kidney failure, finds a study.

In people with Type 2 diabetes, obesity, and chronic kidney disease, bariatric or weight loss surgery can significantly protect kidney function ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small ...

( NewsNation) — Losing muscle mass isn’t the only potential side effect of taking weight loss medications such as Ozempic: ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent.

Kids as young as 6 years old could soon be allowed access to a weight loss drug, similar to Ozempic, to help reduce obesity.

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...